Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Alendronate MeSH Descriptor Data 2025


MeSH Heading
Alendronate
Tree Number(s)
D02.705.429.500.100
Unique ID
D019386
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D019386
Scope Note
A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Entry Term(s)
4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
Alendronate Monosodium Salt, Trihydrate
Alendronate Sodium
Aminohydroxybutane Bisphosphonate
Fosamax
MK-217
Pharm Action
Bone Density Conservation Agents
Registry Numbers
X1J18R4W8P
0
2UY4M2U3RA
Related Numbers
121268-17-5
2UY4M2U3RA
66376-36-1
Previous Indexing
Diphosphonates (1987-1996)
Public MeSH Note
1997; ALENDRONATE was indexed under DIPHOSPHONATES 1987-1996
History Note
1997 (1987)
Date Established
1997/01/01
Date of Entry
1996/06/10
Revision Date
2018/02/28
Alendronate Preferred
MK-217 Related
Fosamax Related
Alendronate Sodium Narrower
Alendronate Monosodium Salt, Trihydrate Narrower
page delivered in 0.129s